Synapse
⌘+K
Sign In
Sign Up for Free
Synapse
Sign In
Sign Up for Free
Home
Communities
Explore
More
Language
English
English
Life Raft Group
h-index: 9
Total citations: 275
Total papers: 32
Homepage:
https://liferaftgroup.org/
Recent papers from Life Raft Group
Expert Perspectives on TGCT and the Outcomes of the Phase 3 MANEUVER Study of Pimicotinib Presented at ASCO and ESMO 2025: A Podcast Discussion
Advances in Therapy · 2026
Predicting clinical sensitivities of PDGFRA exon 18 mutations to imatinib and avapritinib to optimize gastrointestinal stromal tumor treatment
Cancer Research Communications · 2026
Neighborhood-level disadvantage and disparities in treatment and recurrence in tenosynovial giant cell tumor.
Journal of Clinical Oncology · 2026
Clinical characteristics and outcomes of germline and sporadic NF1-associated gastrointestinal stromal tumors: Insights from a real-world patient registry.
Journal of Clinical Oncology · 2026
Adjuvant Imatinib or Observation in Patients With Gastrointestinal Stromal Tumors With KIT Exon 9 Mutations
JAMA Oncology · 2026
Pediatric patients with tenosynovial giant cell tumor: real-world evidence from an observational registry
Orphanet Journal of Rare Diseases · 2026
Systematic elucidation and pharmacologic targeting of non-oncogene dependencies in imatinib-resistant gastrointestinal stromal tumor
2025
Single Nuclei-Derived Molecular Subtypes of Gastrointestinal Stromal Tumors Correlate with Clinicopathologic Features and Predict Clinical Outcomes
2025
Localized and diffuse tenosynovial giant cell tumor: real-world results from a patient observational registry
Future Oncology · 2025
A Review of Genomic Testing and SDH ‐ Deficiency in Gastrointestinal Stromal Tumors: Getting to the GIST
Cancer Medicine · 2025
Leveraging Patient Engagement Through Collaboration for Improved Global Health Outcomes in Sarcoma
American Society of Clinical Oncology Educational Book · 2024
Localized GIST in Hispanic population in North and South America.
Journal of Clinical Oncology · 2024
Gastrointestinal Stromal Tumor Patients with Molecular Testing Exhibit Superior Survival Compared to Patients without Testing: Results from the Life Raft Group (LRG) Registry
Cancer Investigation · 2023
Barriers to mutational testing in patients with gastrointestinal stromal tumors (GIST) – a survey of life raft group members
BMC Gastroenterology · 2022
Barriers to Mutational Testing in Patients with Gastrointestinal Stromal Tumors (GIST) – A Survey of Life Raft Group Members
2022
Barriers to Mutational Testing in Patients with Gastrointestinal Stromal Tumors (GIST) – A Survey of Life Raft Group Members
2021
Advancing the Use of Mobile Technologies in Clinical Trials: Recommendations from the Clinical Trials Transformation Initiative
Digital Biomarkers · 2019
Mutational Testing in Gastrointestinal Stromal Tumor
Current Cancer Drug Targets · 2019
Genomic aberrations in cell cycle genes predict progression of KIT-mutant gastrointestinal stromal tumors (GISTs)
Clinical Sarcoma Research · 2019
Survival of gastrointestinal stromal tumor patients in the imatinib era: life raft group observational registry
BMC Cancer · 2012